MAPT and Alzheimer disease: The complicated pathogenic mechanism of AD has been significantly studied over the last century, which manifests different biomarkers, including the accumulation of Aβ peptides, tau pathology, dysregulation of lipidology, and the activation of innate immune reaction in the human central nervous system.